Jove
Visualize
お問い合わせ

関連する概念動画

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

30
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

33
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
33
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

28
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
28
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

1.4K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー
  1. ホーム
  2. コラーゲンxvは心臓機能を保ち,心筋梗塞後の病理的な再構成から保護する.
  1. ホーム
  2. コラーゲンxvは心臓機能を保ち,心筋梗塞後の病理的な再構成から保護する.

関連する実験動画

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

8.6K

コラーゲンXVは心臓機能を保ち,心筋梗塞後の病理的な再構成から保護する.

Sanna-Maria Karppinen1, Miki Aho1, Zoltan Szabo2,3

  • 1ECM-Hypoxia Research Unit, Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.

The FEBS journal
|August 20, 2025

PubMed で要約を見る

まとめ
この要約は機械生成です。

コラーゲンXVは,心筋梗塞 (MI) の後の心臓の構造と機能に不可欠です. 心臓発作の後,心臓の硬化,機能障害,そして左心室の不良な改造を引き起こします.

キーワード:
コラーゲンXV細胞外マトリックス改造繊維症心臓発作の傷組織の硬化

さらに関連する動画

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.2K
An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice
09:29

An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice

Published on: July 14, 2023

902

関連する実験動画

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

8.6K
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.2K
An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice
09:29

An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice

Published on: July 14, 2023

902

科学分野:

  • 心血管生物学
  • 細胞外マトリックス研究
  • 心筋梗塞 病理学

背景:

  • 心筋梗塞 (MI) の後の左心室 (LV) の改造と線維症を理解することは,心臓病理学にとって極めて重要です.
  • コラーゲンXV (ColXV) は心臓組織の整体性に関与しています.

研究 の 目的:

  • 人間の心筋梗塞におけるColXV発現を分析する.
  • マウスにおける急性心筋梗塞 (AMI) の後の心臓応答に対するColXV欠乏の影響を評価し,繊維生成と組織硬化に焦点を当てた.

主な方法:

  • 人間の心筋梗塞のサンプルで,ColXVの発現を分析した.
  • マウスはAMI誘導のためにLAD結合を受けた.
  • 心臓の機能と再構成は,エコーカルディオグラフィー,弾性測定,免疫ヒストケミストリー,超構造分析によって評価された.

主要な成果:

  • ヒトの心臓発作の傷跡では,ColXVの発現が高かった.
  • Col15a1- / - マウスは,LVの硬化,線維症に関連する遺伝子アップレギュレーション,およびAMI後の傷痕超構造の障害を示した.
  • ノックアウトしたマウスは心臓機能の障害,エジェクション分数の減少,および重要なLVの改造を示した.

結論:

  • ColXVはAMI後の心臓の構造と機能を維持するために不可欠です.
  • コルXV欠乏症は制御不能な再形成,脆弱な傷跡,そして硬くなった左心室を引き起こし,より重度の心臓の現象型につながります.
  • これらの発見は,心臓修復におけるColXVの役割を強調し,心臓発作の回復に対する潜在的な治療効果を示唆しています.